Showing results (31-40 of 318) with videos related to

Sort By:
Pageof 32
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|May 17, 2018
[Analysis of the First Diagnosis Symptom and Its Influencing Factors in 500 Patients with Lung Cancer]Xin Zhang, Puyuan Xing, Xuezhi Hao, et al.
Briefings in Bioinformatics|August 9, 2021
Aperture: alignment-free detection of structural variations and viral integrations in circulating tumor DNAHongchao Liu, Huihui Yin, Guangyu Li, et al.
Thoracic Cancer|June 28, 2021
Concurrent chemotherapy and first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first-line treatment in advanced lung adenocarcinoma harboring an EGFR mutationZiyi Xu, Xuezhi Hao, Lin Lin, et al.
Cancer Medicine|April 16, 2023
Heterogeneity in intracranial relapses after complete resection of lung adenocarcinoma: Distinct features of brain-only relapse versus synchronous extracranial relapseFei Xu, Junling Li, Puyuan Xing, et al.
Cancer Innovation|December 13, 2023
Adjuvant and neo-adjuvant immunotherapy in resectable non-small cell lung cancer (NSCLC): Current status and perspectivesZiyi Xu, Zihua Zou, Xuezhi Hao, et al.
Thoracic Cancer|July 8, 2016
Clinical effect of pemetrexed as the first-line treatment in Chinese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancerDi Ma, Xuezhi Hao, Yan Wang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|March 21, 2012
[Efficacy of pemetrexed as second-line therapy or beyond in patients with advanced non-small cell lung cancer]Junling Li, Jing Wang, Xuezhi Hao, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 21, 2016
[Clinicopathologic Features and Prognostic Implications in 72 Cases 
with Lung Adenosquamous Carcinoma]Xi Wu, Junling Li, Shulan Chen, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|October 21, 2016
[Nimotuzumab Combined with Chemotherapy as Second- or Later-line 
in the Treatment of Advanced Lung Squamous Cell Carcinoma]Yang Luo, Junling Li, Yan Wang, et al.
Oncotarget|November 12, 2016
Clinical data from the real world: efficacy of Crizotinib in Chinese patients with advanced ALK-rearranged non-small cell lung cancer and brain metastasesPuyuan Xing, Shouzheng Wang, Xuezhi Hao, et al.
Pageof 32